We have located links that may give you full text access.
The Successful Treatment of Mpox with Brincidofovir in Renal Transplant Recipients - A report of 2 cases.
International Journal of Infectious Diseases : IJID 2024 March 22
An mpox outbreak was declared in July 2022 by the world health organization (WHO). It causes a mild self-limiting disease however; in immunosuppressed hosts, it tends to cause severe disseminated infection. Most cases of mpox in sold organ transplant (SOT) recipients reported in the literature were treated with Tecovirimat. Here we report two cases of severe disseminated mpox infection in renal transplant recipients that were successfully treated with Brincidofovir. Both patients were discharged from the hospital with no immediate significant side effects from Brincidofovir reported until the submission of this report.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app